SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.
TSE Prime
¥1,305.00
-1.29%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Comfortable interest cover: operating profit covers interest about 9.1 times.
- Return on equity is moderate at 11%.
- Net profit margin is 14%.
- Sales have compounded about 16% a year over five years.
- Has paid a dividend in each of the last 5 years on record.
!Watch-points
- Higher leverage: debt-to-equity of 1.42 is above 1.
- Return on capital employed is on the lower side at 4%.
- Profit growth has been slow over five years (about -11% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
0.74
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreWeak
1 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap¥543億
Current Price¥ 1,305.00
High / Low¥ 2,005.00 / 1,067.00
Stock P/E11.89066
Book Value¥ 1,035.76
Dividend Yield3.78%
ROCE4.04%
ROE11.00%
Debt to Equity1.42
Current Ratio1.09
P/B Ratio1.301873
EPS¥ 109.69
PAT Margin14.04%
ICR9.05
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity